These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses. Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251 [TBL] [Abstract][Full Text] [Related]
5. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV. Talesnik E; Vial PA; Labarca J; Méndez C; Soza X J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960 [TBL] [Abstract][Full Text] [Related]
6. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Koskela M Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065 [TBL] [Abstract][Full Text] [Related]
7. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. Anttila M; Eskola J; Ahman H; Käyhty H J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841 [TBL] [Abstract][Full Text] [Related]
8. Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniques. Zigterman GJ; Verheul AF; Ernste EB; Rombouts RF; De Reuver MJ; Jansze M; Snippe H; Willers JM J Immunol Methods; 1988 Jan; 106(1):101-7. PubMed ID: 3339246 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates. Beuvery EC; van Rossum F; Nagel J Infect Immun; 1982 Jul; 37(1):15-22. PubMed ID: 6809623 [TBL] [Abstract][Full Text] [Related]
10. Human memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune response. Moens L; Wuyts M; Meyts I; De Boeck K; Bossuyt X J Immunol; 2008 Oct; 181(8):5306-12. PubMed ID: 18832686 [TBL] [Abstract][Full Text] [Related]
11. Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen. Leiva LE; Monjure H; Sorensen RU J Clin Immunol; 2015 Feb; 35(2):206-12. PubMed ID: 25504423 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response. Rodriguez ME; van den Dobbelsteen GP; Oomen LA; de Weers O; van Buren L; Beurret M; Poolman JT; Hoogerhout P Vaccine; 1998 Dec; 16(20):1941-9. PubMed ID: 9796048 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide--protein conjugate vaccine is decreased by admixture of high doses of free saccharide. Peeters CC; Tenbergen-Meekes AM; Poolman JT; Zegers BJ; Rijkers GT Vaccine; 1992; 10(12):833-40. PubMed ID: 1455909 [TBL] [Abstract][Full Text] [Related]
14. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm. Wu D; Ji S; Hu T Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485 [TBL] [Abstract][Full Text] [Related]
15. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740 [TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides. Chudwin DS; Artrip SG; Schiffman G Clin Immunol Immunopathol; 1987 Jul; 44(1):114-21. PubMed ID: 3297436 [TBL] [Abstract][Full Text] [Related]
17. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Briles DE; Forman C; Horowitz JC; Volanakis JE; Benjamin WH; McDaniel LS; Eldridge J; Brooks J Infect Immun; 1989 May; 57(5):1457-64. PubMed ID: 2707854 [TBL] [Abstract][Full Text] [Related]
18. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Soininen A; Seppälä I; Nieminen T; Eskola J; Käyhty H Vaccine; 1999 Apr; 17(15-16):1889-97. PubMed ID: 10217586 [TBL] [Abstract][Full Text] [Related]
19. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Barrett DJ; Ayoub EM Clin Exp Immunol; 1986 Jan; 63(1):127-34. PubMed ID: 3955880 [TBL] [Abstract][Full Text] [Related]
20. Specific antibodies to diphtheria toxin and type 6A pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen. Porro M; Costantino P; Viti S; Vannozzi F; Naggi A; Torri G Mol Immunol; 1985 Aug; 22(8):907-19. PubMed ID: 4047043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]